Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads

Clinical trial NCT03023904 · WITHDRAWN

Trial details

NCT number: NCT03023904
Sponsor: Vanderbilt-Ingram Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer

Start date: 2017-12-29
Primary completion: 2019-07-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.